These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 7775612)

  • 1. Patient information leaflets on over-the-counter (OTC) medicines: the manufacturer's perspective.
    Bradley B; McCusker E; Scott E; Li Wan Po A
    J Clin Pharm Ther; 1995 Feb; 20(1):37-40. PubMed ID: 7775612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient information leaflets--helpful guidance or a source of confusion?
    Bjerrum L; Foged A
    Pharmacoepidemiol Drug Saf; 2003; 12(1):55-9. PubMed ID: 12616848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Readability of patient information leaflets on over-the-counter (OTC) medicines.
    Bradley B; Singleton M; Li Wan Po A
    J Clin Pharm Ther; 1994 Feb; 19(1):7-15. PubMed ID: 8188795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in Side Effect Risk Communication in Patient Information Leaflets over the Past Decade: Results of a Survey.
    Harris K; Dickinson R; Raynor DK; MacDonald J; Knapp P
    Drug Saf; 2015 Aug; 38(8):721-7. PubMed ID: 26100144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of bilingual product information labels on Spanish-speaking adults' ability to comprehend OTC information.
    Sansgiry SS; Chanda S; Shringarpure GS
    Res Social Adm Pharm; 2007 Dec; 3(4):410-25. PubMed ID: 18082876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Drug information for patients (Package Leaflets), and user testing in EU].
    Yamamoto M; Doi H; Furukawa A
    Yakugaku Zasshi; 2015; 135(2):277-84. PubMed ID: 25747226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and evaluation of user-tested Thai patient information leaflets for non-steroidal anti-inflammatory drugs: Effect on patients' knowledge.
    Jarernsiripornkul N; Phueanpinit P; Pongwecharak J; Krska J
    PLoS One; 2019; 14(1):e0210395. PubMed ID: 30625196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Over the counter drugs--a new era in Israel].
    Abadi-Korek I; Vaknin S; Marom E; Shemer J; Luxenburg O
    Harefuah; 2011 Jan; 150(1):29-32, 69, 68. PubMed ID: 21449153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How useful are medication patient information leaflets to older adults? A content, readability and layout analysis.
    Liu F; Abdul-Hussain S; Mahboob S; Rai V; Kostrzewski A
    Int J Clin Pharm; 2014 Aug; 36(4):827-34. PubMed ID: 24986267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Receipt and use of spoken and written over-the-counter medicine information: insights into Australian and UK consumers' experiences.
    Tong V; Raynor DK; Aslani P
    Int J Pharm Pract; 2018 Apr; 26(2):129-137. PubMed ID: 28544204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of Prescription Drug Information Leaflets: Impact of Cognitive Effort and Patient Involvement on Prescription Medication Information Processing.
    Patel HK; Bapat SS; Bhansali AH; Sansgiry SS
    Ther Innov Regul Sci; 2018 Jan; 52(1):118-129. PubMed ID: 29714618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient information leaflets for antidepressants: are patients getting the information they need?
    Haw C; Stubbs J
    J Affect Disord; 2011 Jan; 128(1-2):165-70. PubMed ID: 20656359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How much information about the benefits of medicines is included in patient leaflets in the European Union? - A survey.
    Dickinson R; Raynor DK; Knapp P; MacDonald J
    Int J Pharm Pract; 2017 Apr; 25(2):147-158. PubMed ID: 27405658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patients' knowledge and perceptions of the side-effects of OTC medication.
    Hughes L; Whittlesea C; Luscombe D
    J Clin Pharm Ther; 2002 Aug; 27(4):243-8. PubMed ID: 12174025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physician-patient communication about over-the-counter medications.
    Sleath B; Rubin RH; Campbell W; Gwyther L; Clark T
    Soc Sci Med; 2001 Aug; 53(3):357-69. PubMed ID: 11439819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of instructions in patient information leaflets for the use of intranasal corticosteroid sprays: an observational study.
    Rollema C; van Roon EM; Schilder AG; de Vries TW
    BMJ Open; 2019 Jan; 9(1):e026710. PubMed ID: 30647049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How (not) to inform patients about drug use: use and effects of negations in Dutch patient information leaflets.
    Burgers C; Beukeboom CJ; Sparks L; Diepeveen V
    Pharmacoepidemiol Drug Saf; 2015 Feb; 24(2):137-43. PubMed ID: 25044310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of Australian dermatological postoperative patient information leaflets: Should we have a national checklist?
    Hunt WT; O'Sullivan NA; Donnelly A
    Australas J Dermatol; 2018 May; 59(2):118-123. PubMed ID: 28425573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of Information Anxiety and Information Load on Processing of Prescription Drug Information Leaflets.
    Bapat SS; Patel HK; Sansgiry SS
    Pharmacy (Basel); 2017 Oct; 5(4):. PubMed ID: 29035337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using alternative methodologies for evaluating patient medication leaflets.
    Krass I; Svarstad BL; Bultman D
    Patient Educ Couns; 2002 May; 47(1):29-35. PubMed ID: 12023098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.